Recent update of the 2017 Korean Association for the Study of the Liver (KASL) treatment guidelines of chronic hepatitis C: Comparison of guidelines from other continents, 2017 AASLD/IDSA and 2016 EASL
Jong Eun Yeon
Clin Mol Hepatol. 2018;24(3):278-293.   Published online 2018 May 2     DOI: https://doi.org/10.3350/cmh.2018.1002
Citations to this article as recorded by Crossref logo
Comparison of the Clinical Characteristics and Outcomes between Leprosy-Affected Persons in Sorokdo and the General Population Affected by Chronic Hepatitis C in Korea
Young-Hwan Ahn, Hyungcheol Park, Myeon Jae Lee, Dong Hyun Kim, Sung Bum Cho, Eunae Cho, Chung Hwan Jun, Sung Kyu Choi
Gut and Liver.2019; 13(5): 549.     CrossRef
The remaining challenges of HCV treatment in the direct‐acting antivirals era
Beom Kyung Kim, Sang Hoon Ahn
Journal of Gastroenterology and Hepatology.2019; 34(11): 1891.     CrossRef
An integrated analysis of elbasvir/grazoprevir in Korean patients with hepatitis C virus genotype 1b infection
Youn Jae Lee, Jeong Heo, Do Young Kim, Woo Jin Chung, Won Young Tak, Yoon Jun Kim, Seung Woon Paik, Eungeol Sim, Susila Kulasingam, Rohit Talwani, Barbara Haber, Peggy Hwang
Clinical and Molecular Hepatology.2019; 25(4): 400.     CrossRef